Ertapenem how supplied: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ertapenem}} | {{Ertapenem}} | ||
{{CMG}} | {{CMG}} | ||
==How Supplied== | ==How Supplied== | ||
INVANZ is supplied as a sterile lyophilized powder in single dose vials containing ertapenem for intravenous infusion or for intramuscular injection as follows: | INVANZ is supplied as a sterile lyophilized powder in single dose vials containing ertapenem for intravenous infusion or for intramuscular injection as follows: | ||
| Line 20: | Line 17: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
| Line 26: | Line 22: | ||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Revision as of 01:26, 26 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
How Supplied
INVANZ is supplied as a sterile lyophilized powder in single dose vials containing ertapenem for intravenous infusion or for intramuscular injection as follows:
No. 3843—1 g ertapenem equivalent
NDC 0006-3843-71 in trays of 10 vials.
INVANZ is supplied as a sterile lyophilized powder in single dose ADD-Vantage® vials containing ertapenem for intravenous infusion as follows:
No. 3845—1 g ertapenem equivalent
NDC 0006-3845-71 in trays of 10 ADD-Vantage® vials.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021337s018lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.